The Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta Yonivyapada

An Open Label Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta Yonivyapada - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061928

Enrollment

Registered

2024-01-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient suffering from udavarta Yoni Vyapada 2. Married or unmarried patient of age group 20 to30 yrs 3. Patient having pain during Menstruation 4. Patient having painful menses as compared to previous menses 5. Patient ready for clinical trial

Exclusion criteria

Exclusion criteria: Hypothyroidism, HIV, HbsAg, VDRL, prolactaemia, tuberculosis,utrine fibroid,complex ovarian cyst, dermoid cyst, tubo-ovarian mass, cervical polyp or growth. 5 Patients suffering from uterine synechiae, endometriosis or malignancy. 6 Pregnancy lactating and post natal female.

Design outcomes

Primary

Measure	Time frame
The effect of Hingvadi Gutika 250 mg BD orally in Udavarta YonivyapadaTimepoint: 18 months	—

Secondary

Measure	Time frame
Literature study of Udavarta Yonivyapada. Preparation of Hingvadi Gutika To Observe adverse effect if any of Hingvadi Gutika .Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Kalpana B Ayare

Sumatibhai saha Ayurveda Mahavidyalaya

drkalpanaayare@gmail.com9423295630

Outcome results